8-K: Modivcare Announces Q4 and Full Year 2024 Earnings Release Date and Adjourns Special Stockholder Meeting
8-K Filing
Modivcare Inc. will report its Q4 and full year 2024 financial results on March 6, 2025, and has adjourned its special stockholder meeting to March 13, 2025, to allow for the dissemination of these results.
Summary
- Modivcare Inc. has scheduled the release of its fourth quarter and full year 2024 financial results for March 6, 2025, after market close.
- A conference call will be held at 5:00 p.m. Eastern Time on the same day to discuss the results.
- The company has also adjourned its special meeting of stockholders from March 3, 2025, to March 13, 2025, at 10:00 a.m. Mountain Time.
- The adjournment is to ensure that the financial results are released before the special meeting.
- The record date for the special meeting remains January 22, 2025, and previously submitted proxies will be voted at the adjourned meeting unless revoked.
Sentiment
Score: 6
Explanation: The announcement is neutral, providing information about the earnings release and meeting adjournment. It doesn't contain overtly positive or negative sentiment.
Positives
- The company is providing its financial results before the special meeting, allowing stockholders to make informed decisions.
Risks
- The announcement contains forward-looking statements that are subject to risks and uncertainties, as detailed in the company's SEC filings.
- Actual events could differ materially from those expressed or implied in the forward-looking statements.
Future Outlook
The company's intentions regarding the special meeting adjournment are forward-looking statements and are subject to risks and uncertainties.
Industry Context
This announcement is typical for publicly traded companies that need to release financial information before significant corporate events like special meetings.
Stakeholder Impact
- Shareholders are impacted by the timing of the financial release and the special meeting adjournment.
- The adjournment allows shareholders to make more informed decisions.
Next Steps
- Stockholders should review the Q4 and full year 2024 financial results when released.
- Stockholders should review the definitive proxy statement and vote at the adjourned special meeting on March 13, 2025.
Key Dates
| Date | Description |
|---|---|
| January 22, 2025 | Record date for the special meeting of stockholders. |
| February 3, 2025 | Definitive proxy statement for the special meeting filed with the SEC. |
| March 3, 2025 | Original date of the special meeting of stockholders (adjourned). |
| March 6, 2025 | Date of Q4 and full year 2024 financial results release and conference call. |
| March 13, 2025 | New date for the special meeting of stockholders. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.